Professional Documents
Culture Documents
-
⇐← *I -
Malak&Manar121
'
ÉÉ ⑤
3£
-
"
→
I
.gs#-eepj..g
,
}
* The History of Chemotherapy
Narrow spectrum of
Broad-spectrum antibiotics Extended-spectrum antibiotics
microbial activity
Effective against
affect a broad range of
drugs that affect a gram-negatives as
gram-positive or gram-
narrow range of well as gram-
microbial types. negative bacteria. positives.
Bactericidal Bacteriostatic
"yy
construction (especially gram-positives) structures
- -
:@ d
•
davulaniccacid.CA/Augmentin (amoxicillin + CA) 8.* Penicillins plus β-lactamase inhibitors {¥-1
-
④
a noncompetitive inhibitor of penicillinase Augmin8% .bgg clavulanic acid Jl8Gd
II.go.pencillinasedp-jwactive.si#e-JIE*g-rs6Hsj :& .
• (
Kitsap.AM/penici11inaseJ1f-j1pYw
resistant to penicillinase 3 Narrow spectrum, only gram-positives 2 Semisynthetic penicillins 18k¥ oxacillinJ1*i↳58%A④
g-
g Penicillins plus β-lactamase inhibitors)
,
Extended-spectrum
]→ Aminopenicillins .
Extended-spectrum
a1@IHjGIi-I_w-pIH.cjooDJ1JI.o
Substitute a C for an S and add a double bond to the penicillin nucleus
doripenem Broad spectrum
*
-156 ow n 1*-1 ✓
'
synthesis jlk.fm-1g
I%
(INH)
,I# g) 8 JIG ④
a:-, Wb He b.I:-p aeruginosa ← ↳ third Away
. + E- It second J¥÷
•
third I b- Is:b :@ →it ↳ idles-6
Nitrofurantoin *Converted to intermediates that attack bacterial ribosomal proteins
*Synthesized chemically
*Treatment for urinary bladder infections
fs
*Change the shape of the 30S subunit of the ribosome
examples .
parasite -42*11-341,06%1
*Broad spectrum; penetrate tissues, making them valuable against rickettsias and chlamydias
*Can suppress normal intestinal microbiota
Macrolides
Contain a macrocyclic lactone ring
Erythromycin *Narrow spectrum against gram-positives
Streptogramins
Attach to the 50S subunit HUGS gram-positive) / jog .
largesubunitjls-WI-j-mx-q.K.s-H-T-drugJ-I.sc
& small subunits @
Oxazolidinones Bind to the 50S/30S subunit interface
*Synthetic; combat MRSA (linezolid) , MRSA JIG *
*
Pleuromutilins Retapamulin: topical and effective against gram- positives
-
-8066*-06*5 .SI#g.--j- ④
S.5ossubunittlbd.is.W.1.CH#J
Streptogramins 2 Chloramphenicol 1
1s.30ssubunitJ1bI @s.30s150ssubunitinterfacebt.w
.
) Glycylcyclines 2 twig ) Aminoglycosides
.
Oxazolidinones G-
-
2
Glycylcyclines 2 Chloramphenicol IS.Broadspectrum.G-q.MG
-
Macrolides 1 3
3 Streptogramins 2 9. gram-positive J1j-@
-
Pleuromutilins a
d
8@d.CtopicalJqosd.3.W
-0,6%5×16 Erythromycin
suppress bone marrow and affect blood cell formation Chloramphenicol s.SN#.k-u1Ii-W-W- 4
5
!MRsAdñ& a
-
6
gentamicin 3 2 19 Aminoglycosides e. JIA -Ag
-
neomycin Streptomycin
7-
Erythromycin 9 Macrolides 81 I-III g-
*used for skin infections
Daptomycin
* Attacks the bacterial cell membrane
w w.tsoe#7- .*treatmentJl&M- .
ointments *Inhibitors of Cell wall. inhibitor of Protein Synthesis
*works against gram-positives
Jo
.
Competitively bind to the enzyme for para- aminobenzoic
PABA J1÷qjÑ*A acid (PABA), a folic acid precursor
Sulfamethoxazole 4. ¥5 .
because 8
(Sulfamethoxazole is a structural analog of PABA)
Sulfamethoxazole and Trimethoprim
Inhibit the folic acid synthesis needed for nucleic
acid and protein synthesis
Competitive Inhibition of Essential Metabolites
IetrahydrofolicacidJIDihydrofolicacid.gr#mgDihydrofo1ic acid
pABA-JII.si#-.&.sJ1@-I.s-sH1*0sulfonamidsJ1t--
I.
ÑJ←
.oÉJ1§o&a Trimethoprim JI
.
-
¥10.6 :@ Sulfamethoxazole JI 8 Haim
S.is#-wo.b
Is
⇐ H¥±↳J.ws/2hydrofo1icacidJ-*g.pABAJls.p-jJ#IbJ.wopA-BAJI !
TrimethoprimIs.¥s Dihydrofolicaidjls
•
. .
•
Sulfamethoxazole JK .
④ Note
*
Imidazoles topical; treat cutaneous mycoses
Triazole
treat systemic fungal infections Coral
-
, injection ) .
Allylsmines
Allylamines For azole-resistant infections
w w.igw.RNAJ-s-6-dsw-s-W.sc#g.- Ii
*Produced by Penicillium
Griseofulvin *Inhibits microtubule formation
*Active against superficial dermatophytes
I 8%-6*0
Amphotericin B 2 Tetracyclines 18 Streptomyces JI
.&q← -61*2 drugs -6,6
.
2
• Allylamines JIosbhj-w.S.AzolesJ.jp#fungiJ-o8lit
d.
from the host cell
Prevent viral uncoating KANZAKI *
.
•
wide spectrum antiviral d
-
•
Deoxyguanosine t.SI#-g
iv.Wide 85%6 ← w out ④
. -46611*1 @ jÉ1-•
•
DNA JI @
•
5%6.6 DNA polymerase I go false nucleotide ↳ Ew ,
-
8 Antiviral drugs I w ⑥, ⑤ ↳ A
Produced by viral-infected
5 Imiquimod Promotes production of :
Interferons cells to inhibit further
spread of the infection
www.iwp-w-g-w.d-ossb.dk#
MAKE
i. ↳% ig @
Antiprotozoan Drugs
| |
Antiprotozoan Drugs Treat Notes
:/ I
Antihelminthic Drugs Treat Notes
Mechanisms of Resistance
Or destruction
Of the drug
• rapid j€ -
(ejection)
synthesizing very large amounts of enzyme (against which the drug is targeted.)
Using antibiotics for the common cold and other inappropriate conditions
Antibiotic Safety
l
Therapeutic index: risk versus benefit
Damage to organs
I Phage therapy
noooooo
كل ما اضطريت ازيد الجرعة يعني البكتيريا
highly sensitive
Selective toxicity selectively finding and destroying pathogens without damaging the host
Antimicrobial drugs synthetic substances that interfere with the growth of microbes صناعي
l
Persister cells microbes with genetic characteristics allowing for their survival when
exposed to an antibiotic
Synergism the effect of two drugs together is greater than the effect of
either alone
Antagonism the effect of two drugs together is less than the effect of
either alone
ج
"سبَُلن َا َِّ "َوَما َلن َآ أ ََّال َنت ََوَّكَل َعَلى ٱ
ُ هلل َوَقْد َهَدٰىن َا
Malak&Manar121